Background Percutaneous transluminal coronary angioplasty PTCA is a widely acceptable treatment for ischemic heart disease. However, restenosis after successful PTCA, which develops in 20 30 of all patients, remains a serious late complication. This study was performed to compare the efficacy of cilostazol with that of ticlopidine for the prevention of stent restenosis. Materials and Methods Fifty three patients who had undergone coronary stent implantation were divided into group A n 25 receiving 100 mg aspirin and 200 mg cilostazol and group B n 28 receiving 100 mg aspirin and 500 mg ticlopidine, between
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.